'We’ve seen several high-profile transactions in life sciences, resulting in big exits for investors in the private and public markets,' said Toby Sykes, managing director of Intermediate Capital Group.
The firm's deals in 2024 include AuditBoard, CTAIMA, Cube, Empyrean, Focus Group, Induver, Ivalua and Ncontracts.
Consultancy companies covering management, climate and sustainability, and IT were among the deals.
GPs are finding attractive price-to-earnings ratios in the UK – as well as willing sellers.
The iconic brand’s recognition value, coupled with dance’s health benefits, were among the target company’s attractions for the PE firm.
Family office Vonrosen is entirely focused on direct investments – usually with majority control – but is sector-agnostic, its founder tells PE Hub.
Private equity has put its faith in the travel industry and shaken off anti-tourism concerns.
'There’s an opportunity to continue to take advantage of that increasing spending in the vet space, while also adding additional customers, services and capabilities,' said RF Investment Partners' Collin Abert.
Thoma Bravo, Great Hill Partners, Inflexion and Brookfield have signed deals where they recently opened offices.
Frazier Healthcare Partners, Waud Capital Partners and RiverGlade Capital are among the PE firms backing home-based care.